Edwards Lifesciences Corp

NYSE:EWHealthcareCBOE:SPESGSTOXX:EDD24BP

$87.22+0.72%At closeAt close · Tue 20 Oct · ≈ AED 320.32 · Market cap $50.27B · Next earnings Thu 29 Oct · Extended $87.01 −0.24%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	74.9%	76.6%	78.3%	79.3%	79.5%	78.1%	—	—
Operating margin	29.5%	30.8%	31.6%	28.5%	25.3%	27.0%	27.0%	+0.0 pts
Net margin	18.8%	28.7%	28.3%	28.0%	76.7%	17.7%	17.7%	+0.0 pts
EBITDA margin	24.5%	36.1%	36.4%	30.6%	31.7%	23.6%	—	—
Return on equity	18.0%	25.8%	26.2%	21.1%	41.8%	10.4%	10.4%	+0.0 pts
Return on assets	11.4%	17.7%	18.4%	15.0%	32.0%	7.8%	7.8%	+0.0 pts
Return on capital employed	20.4%	21.6%	23.4%	17.5%	11.9%	13.8%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	9.6%	8.1%	8.3%	7.3%	5.4%	5.1%	—	—
Interest coverage	58.4×	64.9×	65.0×	81.1×	69.6×	0.0×	—	—
Current ratio	3.5×	3.1×	3.0×	3.4×	4.2×	3.7×	3.7×	+0.0%
Quick ratio	2.6×	2.4×	2.2×	2.6×	3.5×	3.1×	—	—
Cash ratio	1.3×	0.8×	0.8×	0.9×	2.0×	1.6×	1.6×	+0.0%
Asset turnover	0.6×	0.6×	0.6×	0.5×	0.4×	0.4×	—	—
Inventory turnover	1.4×	1.7×	1.3×	1.1×	1.0×	1.2×	—	—
Receivables turnover	7.3×	7.9×	7.7×	6.0×	7.5×	6.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—